Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, surgical headlamps and instrumentation.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.4B | $1.5B | $1.6B | $1.5B | $1.6B | $1.6B |
| Gross profit | $851.0M | — | — | — | — | — |
| Operating income | $151.4M | $197.2M | $238.9M | $111.5M | $28.4M | -$493.4M |
| Net income | $133.9M | $169.1M | $180.6M | $67.7M | -$6.9M | -$516.8M |
| Diluted EPS | $1.57 | $1.98 | $2.16 | $0.84 | -$0.09 | -$6.74 |
| Operating cash flow | $203.8M | $312.4M | $264.5M | $140.0M | $129.4M | $50.4M |
| Free cash flow | $164.9M | $264.4M | $222.1M | $73.1M | $25.0M | -$31.1M |
| Gross margin | 62.0% | — | — | — | — | — |
| Operating margin | 11.0% | 12.8% | 15.3% | 7.2% | 1.8% | -30.2% |
| Net margin | 9.8% | 11.0% | 11.6% | 4.4% | -0.4% | -31.6% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $418.2M | $380.8M | $442.6M | $382.7M | $415.6M | $402.1M | $434.9M | $391.9M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$3.0M | -$8.2M | $35.6M | -$15.5M | -$512.7M | $11.8M | $23.0M | $11.5M |
| Net income | -$12.4M | -$10.7M | $19.5M | -$25.3M | -$484.1M | -$5.4M | -$2.0M | -$4.6M |
| Diluted EPS | -$0.16 | -$0.14 | $0.25 | -$0.33 | -$6.31 | -$0.07 | -$0.03 | -$0.06 |
| Operating cash flow | $40.4M | $22.5M | $50.7M | -$11.3M | $8.9M | $40.9M | $11.8M | $9.8M |
| Free cash flow | $10.7M | -$7.2M | $21.1M | -$40.2M | -$11.2M | $25.8M | -$5.4M | -$5.0M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -0.7% | -2.1% | 8.0% | -4.0% | -123.4% | 2.9% | 5.3% | 2.9% |
| Net margin | -3.0% | -2.8% | 4.4% | -6.6% | -116.5% | -1.3% | -0.5% | -1.2% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-03 | Knight Lea Daniels· EVP & Chief Financial Officer | Tax withholding | 5,226 | $18.05 | $94,329.30 | filing |
| 2026-07-01 | Mosebrook Jeffrey· SVP, Fin & Princ Acct Officer | Tax withholding | 937 | $17.89 | $16,762.93 | filing |
| 2026-05-09 | BRADLEY KEITH | Tax withholding | 882 | $13.92 | $12,277.44 | filing |
| 2026-05-07 | HILL BARBARA B | Award | 6,638 | $0.00 | $0.00 | filing |
| 2026-05-07 | HILL BARBARA B | Award | 17,700 | $0.00 | $0.00 | filing |
| 2026-03-11 | DAVIS ROBERT T. JR.· EVP & President, TT | Tax withholding | 8,487 | $9.61 | $81,560.07 | filing |
| 2026-03-11 | Knight Lea Daniels· EVP & Chief Financial Officer | Tax withholding | 8,089 | $9.61 | $77,735.29 | filing |
| 2026-03-11 | McBreen Michael J.· EVP & President, CSS | Tax withholding | 7,247 | $9.61 | $69,643.67 | filing |
| 2026-03-11 | Veillon-Berteloot Chantal· EVP & CHRO | Tax withholding | 5,420 | $9.61 | $52,086.20 | filing |
| 2026-03-11 | Singh Harvinder· EVP & PRESIDENT, INTERNATIONAL | Tax withholding | 5,190 | $9.61 | $49,875.90 | filing |
| 2026-03-11 | Singh Harvinder· EVP & PRESIDENT, INTERNATIONAL | Tax withholding | 861 | $9.61 | $8,274.21 | filing |
| 2026-03-11 | Mosebrook Jeffrey· SVP, Fin & Princ Acct Officer | Tax withholding | 806 | $9.61 | $7,745.66 | filing |
| 2026-03-11 | Singh Harvinder· EVP & PRESIDENT, INTERNATIONAL | Option exercise | 18,922 | $0.00 | $0.00 | filing |
| 2026-03-10 | McBreen Michael J.· EVP & President, CSS | Tax withholding | 2,354 | $9.55 | $22,480.70 | filing |
| 2026-03-10 | DAVIS ROBERT T. JR.· EVP & President, TT | Tax withholding | 687 | $9.55 | $6,560.85 | filing |
| 2026-03-10 | Singh Harvinder· EVP & PRESIDENT, INTERNATIONAL | Tax withholding | 601 | $9.55 | $5,739.55 | filing |
| 2026-03-10 | Mosebrook Jeffrey· SVP, Fin & Princ Acct Officer | Tax withholding | 341 | $9.55 | $3,256.55 | filing |
| 2026-03-10 | Singh Harvinder· EVP & PRESIDENT, INTERNATIONAL | Option exercise | 1,216 | $0.00 | $0.00 | filing |
| 2026-01-06 | Poul Mojdeh· President & CEO | Tax withholding | 848 | $13.13 | $11,134.24 | filing |
| 2026-01-06 | Poul Mojdeh· President & CEO | Tax withholding | 542 | $13.13 | $7,116.46 | filing |
| 2026-01-06 | Poul Mojdeh· President & CEO | Option exercise | 848 | $0.00 | $0.00 | filing |
| 2026-01-06 | Poul Mojdeh· President & CEO | Option exercise | 542 | $0.00 | $0.00 | filing |
| 2025-11-05 | GRAVES JEFFREY A | Buy | 9,000 | $11.35 | $102,150.00 | filing |
| 2025-10-12 | Singh Harvinder· EVP & PRESIDENT, INTERNATIONAL | Tax withholding | 3,281 | $13.34 | $43,768.54 | filing |
| 2025-10-12 | Singh Harvinder· EVP & PRESIDENT, INTERNATIONAL | Option exercise | 11,965 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.